BioMarin Pharmaceutical Inc. (BIT:1BMRN)

BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	8,643	10,791	15,649	16,588	13,983	13,715
Market Cap Growth	-26.61%	-31.05%	-5.66%	18.63%	1.96%	4.81%
Enterprise Value	7,930	10,324	15,661	16,408	14,040	13,723
PE Ratio	15.44	29.74	110.83	137.99	-252.43	19.49
Forward PE	12.34	17.86	38.98	39.00	85.79	75.56
PEG Ratio	-	0.72	1.07	0.86	2.66	1.75
PS Ratio	3.31	4.39	7.52	9.20	8.80	8.57
PB Ratio	1.68	2.22	3.67	4.19	3.81	3.88
P/TBV Ratio	1.46	2.29	3.73	4.25	3.79	4.09
P/FCF Ratio	14.61	25.72	290.64	350.82	77.76	-550.55
P/OCF Ratio	13.24	21.89	114.18	109.58	53.36	186.69
EV/Sales Ratio	3.01	4.20	7.52	9.10	8.84	8.57
EV/EBITDA Ratio	9.51	21.40	62.72	406.16	634.83	-363.18
EV/EBIT Ratio	10.57	25.84	97.96	-346.50	-198.13	-106.97
EV/FCF Ratio	13.40	24.61	290.85	347.02	78.07	-550.89
Debt / Equity Ratio	0.10	0.11	0.22	0.24	0.25	0.26
Debt / EBITDA Ratio	0.69	1.06	3.75	23.07	41.99	-24.49
Debt / FCF Ratio	0.86	1.22	17.37	19.71	5.16	-37.14
Asset Turnover	0.42	0.41	0.37	0.34	0.31	0.35
Inventory Turnover	0.49	0.50	0.53	0.60	0.64	0.76
Quick Ratio	3.34	2.96	1.45	2.98	2.54	3.07
Current Ratio	5.56	5.33	2.51	4.67	4.16	4.76
Return on Equity (ROE)	11.25%	8.05%	3.51%	3.19%	-1.53%	23.63%
Return on Assets (ROA)	8.41%	5.23%	2.50%	-1.00%	-1.18%	13.69%
Return on Capital (ROIC)	11.47%	7.01%	3.44%	-1.37%	-1.59%	18.85%
Return on Capital Employed (ROCE)	11.80%	7.71%	3.24%	-0.98%	-1.52%	-3.27%
Earnings Yield	6.48%	3.36%	0.90%	0.72%	-0.40%	5.13%
FCF Yield	6.85%	3.89%	0.34%	0.29%	1.29%	-0.18%
Buyback Yield / Dilution	0.39%	0.23%	0.04%	-0.08%	-0.02%	0.14%
Total Shareholder Return	-	0.23%	0.04%	-0.08%	-0.02%	0.14%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.